Contact
Please use this form to send email to PR contact of this press release:
Caladrius Biosciences Completes Enrollment of First Patient Cohort in Phase 2 Trial of CLBS03 to Treat Type 1 Diabetes
TO:
Please use this form to send email to PR contact of this press release:
Caladrius Biosciences Completes Enrollment of First Patient Cohort in Phase 2 Trial of CLBS03 to Treat Type 1 Diabetes
TO: